Huadong Medicine's (SHE:000963) net profit attributable to shareholders in 2024 climbed 24% year on year to 3.51 billion yuan or 2 yuan per share, according to a Shenzhen Stock Exchange filing on Friday.
The attributable profit a year earlier was 2.84 billion yuan or 1.62 yuan per share.
The Chinese drugmaker's operating income increased 3.2% to 41.9 billion yuan from 40.6 billion yuan in the prior year, the filing said.
The company's shares jumped less than 5% in recent trade.
